Global Contrast Media (Contrast Agents) market will reach 6970 million US$ by the end of 2025
Published Date: 2019/1/25
Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.
Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract.
Several types of contrast media are in use in medical imaging and they can roughly be classified based on the imaging modalities where they are used. Most common contrast agents work based on X-ray attenuation and magnetic resonance signal enhancement.
The classification of contrast media includes X-ray & CT contrast media, MRI contrast media, ultrasound contrast media, and the proportion of X-ray & CT contrast media in 2017 is about 86%.
Contrast media is widely used in hospitals and clinics. The most proportion of contrast media is used in hospitals and the revenue in 2017 is 3796 M USD.
North America is the largest consumption place, with a consumption market share nearly 32% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Market competition is intense. GE, Bayer, Bracco Imaging, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Contrast Media (Contrast Agents) market is valued at 4790 million US$ in 2017 and will reach 6970 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2018-2025.
Click to view the full report: https://www.qyresearch.com/index/detail/581316/global-contrast-media-contrast-agents-sales-market
Marketing: sales@qyresearchglobal.com
Media Contact: press@qyresearch.com
评论
发表评论